40
Participants
Start Date
March 31, 2013
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
Peginterferon Lambda-1a
Ribavirin
Peginterferon alfa-2a
Local Institution, Guadalajara
Local Institution, Guadalajara
Local Institution, Hradec Králové
Local Institution, Prague
Local Institution, Ústí nad Labem
Local Institution, Distrito Federal
Local Institution, Mexico City
Local Institution, México
Local Institution, Chungcheongnam-do
Local Institution, Daegu
Local Institution, Gangwon-do
Local Institution, Gyeonggi-do
Local Institution, Gyeonggi-do
Local Institution, Gyeongsangnam-do
Local Institution, Incheon
Local Institution, Seoul
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY